Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-21
1992-07-14
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 6, 546116, A61K 31435, C07D491056
Patent
active
051303205
ABSTRACT:
Novel compounds represented by the formula: ##STR1## wherein R represents hydrogen, optionally substituted alkyl radicals having from 1 to about 10 carbon atoms, optionally substituted alkenyl radicals having from 1 to about 10 carbon atoms, optionally substituted aryl, alkaryl and aralkyl radicals having from about 6 to about 16 carbon atoms and optionally substituted acyl and acyloxy radicals having from about 1 to about 10 carbon atoms, manifest glycosidase inhibition activity.
REFERENCES:
patent: 4348402 (1982-09-01), Kinast et al.
M navu et al., J. Org. Chem., 41, 1831 (1976).
David et al., Tetrahedron, 41, (4), 643 (1985).
Tsuda et al., Chem. Pharm. Bull., 31 (5), 1612 (1983).
Boshagan et al., Carbohydrate Research, 164, 141 (1987).
DeCrescenzo Gary A.
Getman Daniel P.
Bolding James C.
Dentz Bernard
Monsanto Company
Passley Paul L.
Smith Charles E.
LandOfFree
Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycosidase inhibiting 1,3-dideoxy-3-fluoronojirimycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-334856